188 related articles for article (PubMed ID: 3291251)
1. Effects of HLA matching in cadaver renal transplants.
Najarian JS; Migliori RJ; Simmons RL; Ascher NL; Payne WD; Dunn D; Sutherland DE; Fryd DS
Transplant Proc; 1988 Jun; 20(3 Suppl 3):249-56. PubMed ID: 3291251
[No Abstract] [Full Text] [Related]
2. Impact of blood transfusions and HLA on cyclosporine-treated renal transplant recipients.
Kerman RH; Van Buren CT; Lewis RM; Kahan BD
Transplant Proc; 1988 Jun; 20(3 Suppl 3):264-9. PubMed ID: 3291254
[No Abstract] [Full Text] [Related]
3. Cyclosporine A and histocompatibility in kidney transplantation.
Cook DJ; Terasaki PI
Transplant Proc; 1988 Jun; 20(3 Suppl 3):244-8. PubMed ID: 3291250
[No Abstract] [Full Text] [Related]
4. Impact of blood transfusions and HLA matching on national kidney transplant programs: the first Swedish-Norwegian Study of cyclosporine.
Albrechtsen D; Flatmark A; Brynger H; Frödin L; Gäbel H; Groth CG; Lundgren G; Maurer W
Transplant Proc; 1988 Jun; 20(3 Suppl 3):257-60. PubMed ID: 3291252
[No Abstract] [Full Text] [Related]
5. The outcome of repeat cadaveric kidney transplants in recipients managed with cyclosporine.
Smith AY; Van Buren CT; Lewis RM; Kerman RH; Welsh M; Kahan BD
Transplant Proc; 1988 Jun; 20(3 Suppl 3):180-93. PubMed ID: 3291239
[No Abstract] [Full Text] [Related]
6. Survival of cadaveric donor renal allografts in cyclosporine A-treated recipients: the influence of HLA-DR antigen matching.
Madsen M; Fjeldborg O; Graugaard B; Posborg V; Kissmeyer-Nielsen F
Transplant Proc; 1988 Jun; 20(3):369-71. PubMed ID: 3381251
[No Abstract] [Full Text] [Related]
7. The influence of HLA matching in cardiac allograft recipients in a single center.
Raffoux C; Mayor V; Cabrol C; Busson M; Hors J; Colombani J
Transplant Proc; 1987 Oct; 19(5):3559-60. PubMed ID: 3313858
[No Abstract] [Full Text] [Related]
8. Role of class I and class II HLA antigens in cadaveric renal transplantation.
Sengar DP; Couture RA; Raman S; Jindal SL; Lazarovits AI
Transplant Proc; 1987 Aug; 19(4):3422-5. PubMed ID: 3303509
[TBL] [Abstract][Full Text] [Related]
9. The impact of repeated DR mismatching and preformed antibodies on human kidney retransplantation.
Yussim A; Efter T; Shmueli D; Shapira Z
Transplant Proc; 1987 Oct; 19(5):3653-4. PubMed ID: 3313881
[No Abstract] [Full Text] [Related]
10. Predictive factors for immunologic graft failure in cadaver renal transplant recipients.
Pirsch JD; Voss BJ; Roecker EB; Lorentzen DF; Knechtle SJ; Reed A; D'Alessandro AM; Sollinger HW; Kalayoglu M; Belzer FO
Transplant Proc; 1991 Feb; 23(1 Pt 2):1282-3. PubMed ID: 1989213
[No Abstract] [Full Text] [Related]
11. Donor-recipient DR antigen combinations in cadaver renal graft survival: a new approach to recipient selection.
Vereerstraeten P; Dupont E; Andrien M; De Pauw L; Kinnaert P; Toussaint C
Transplant Proc; 1987 Oct; 19(5):3647-50. PubMed ID: 3313879
[No Abstract] [Full Text] [Related]
12. Long-term results in cadaveric renal transplantation under cyclosporine therapy.
Land W; Schneeberger H; Schleibner S; Illner WD; Abendroth D; Hillebrand G; Gokel JM; Albert E; Fornara P
Transplant Proc; 1991 Feb; 23(1 Pt 2):1244-6. PubMed ID: 1989200
[No Abstract] [Full Text] [Related]
13. Effect of DR and DR6 matching on cadaver kidney transplant survival.
Reyman TA; Toledo-Pereyra LH
Transplant Proc; 1987 Feb; 19(1 Pt 1):702-4. PubMed ID: 3274848
[No Abstract] [Full Text] [Related]
14. Role of HLA matching and pretransplant blood transfusions in cyclosporine-treated recipients of cadaveric renal allografts: 2- to 3-year results.
Lundgren G; Albrechtsen D; Brynger H; Flatmark A; Frödin L; Gäbel H; Lindholm A; Maurer W; Möller E; Persson H
Transplant Proc; 1987 Oct; 19(5):3614-8. PubMed ID: 3313870
[No Abstract] [Full Text] [Related]
15. HLA-B, DR matching and cadaver renal allograft survival in New England. New England Organ Bank.
Carpenter CB; Goguen JE; Bradley JW; Turka LA; Cho SI; Milford EL
Transplant Proc; 1989 Feb; 21(1 Pt 1):663-4. PubMed ID: 2650215
[No Abstract] [Full Text] [Related]
16. Beneficial effects of some donor-recipient HLA-DR mismatches on cadaveric graft survival: proposal for a new selection policy of recipients.
Vereerstraeten P; Andrien M; De Pauw L; Dupont E; Goldman M; Abramowicz D; Kinnaert P
Transplant Proc; 1991 Feb; 23(1 Pt 1):385-6. PubMed ID: 1990560
[No Abstract] [Full Text] [Related]
17. No effect of blood transfusions or HLA matching on renal graft success rate in recipients treated with cyclosporine-prednisolone or cyclosporine-azathioprine-prednisolone: the Scandinavian experience.
Brynger H; Persson H; Flatmark A; Albrechtsen D; Frödin L; Tufvesson G; Gäbel H; Weibull H; Möller E; Lundgren G
Transplant Proc; 1988 Jun; 20(3 Suppl 3):261-3. PubMed ID: 3291253
[No Abstract] [Full Text] [Related]
18. Kidney transplantation in sensitized patients.
Opelz G
Transplant Proc; 1987 Oct; 19(5):3737-41. PubMed ID: 3313904
[No Abstract] [Full Text] [Related]
19. Predictors of outcome in cyclosporine-treated recipients of second renal transplants.
Merion RM; Campbell DA; Dafoe DC; Rosenberg L; Rocher LL; Turcotte JG
Transplant Proc; 1988 Jun; 20(3 Suppl 3):194-7. PubMed ID: 3291240
[No Abstract] [Full Text] [Related]
20. Important of HLA matching in cadaveric renal transplantation. A prospective one-center study.
Moen T; Flatmark A; Jervell J; Dahl O; Halvorsen S; Solheim B; Thorsby E
Scand J Urol Nephrol Suppl; 1981; 64():64-71. PubMed ID: 6815795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
